Procter & Gamble has agreed to acquire nutritional supplements company Thorne in an all-cash deal valued at $3.8bn, providing L Catterton with a lucrative exit just three years after taking the business private, according to a report by Bloomberg.
The transaction highlights continued private equity value creation in the health and wellness sector, with L Catterton expected to generate a return of more than $3bn on its investment after acquiring Thorne for approximately $680m in 2023.
For Pro...
Continue Reading
Sign up for FREE to read the full article and access 149K+ alternative investment headlines.